Pomegranate for Blood Pressure Regulation

Research suggests that pomegranate and its bioactive compounds — including ellagitannins, anthocyanins, and flavonoids — may support blood pressure regulation and broader cardiovascular health through mechanisms such as reducing oxidative stress, improving endothelial function, and inhibiting platelet aggregation. The available evidence draws on both laboratory studies and clinical trials, with at least some human studies reporting reductions in blood pressure and slowed atherosclerosis progression associated with regular pomegranate juice consumption. However, the current body of evidence is limited to a single review synthesizing earlier laboratory and clinical work, meaning the overall evidence base remains relatively modest and conclusions should be interpreted with appropriate caution. Larger, well-controlled randomized trials would be needed to more firmly establish the strength, consistency, and practical significance of these effects in diverse populations.